作者: tic-douloureux 時(shí)間: 2025-3-21 22:45
https://doi.org/10.1007/978-3-319-77544-9rs to improve the ability to diagnose and manage BE and EAC as well as in potential chemoprevention therapies. The current management and evolving areas with regards to the prevention, detection, monitoring, and management of BE will be discussed.作者: 油膏 時(shí)間: 2025-3-22 03:51 作者: 羊齒 時(shí)間: 2025-3-22 06:20
https://doi.org/10.1007/978-3-319-41238-2dysplasia in patients with BE. Screening is recommended for patients with non-dysplastic BE. For patients that progress to dysplasia, the current standard approach involves endoscopic mucosal resection and radiofrequency ablation. Highly select early esophageal cancers may in some cases also be mana作者: 逢迎春日 時(shí)間: 2025-3-22 12:03 作者: Canopy 時(shí)間: 2025-3-22 15:09 作者: Canopy 時(shí)間: 2025-3-22 18:49
Book 2020Latest edition and Therapy?will assist specialists from various disciplines, including surgery,radiation therapy, gastroenterology, medical oncology and palliative medicine, in delivering optimal, up-to-date care to the benefit of patients..作者: 送秋波 時(shí)間: 2025-3-22 23:29 作者: Seizure 時(shí)間: 2025-3-23 01:24
,Barrett’s Esophagus: Diagnosis and Management,rs to improve the ability to diagnose and manage BE and EAC as well as in potential chemoprevention therapies. The current management and evolving areas with regards to the prevention, detection, monitoring, and management of BE will be discussed.作者: osteoclasts 時(shí)間: 2025-3-23 09:18 作者: 花束 時(shí)間: 2025-3-23 12:37
Role of Endoscopy in the Diagnosis, Staging, and Management of Esophageal Cancer,dysplasia in patients with BE. Screening is recommended for patients with non-dysplastic BE. For patients that progress to dysplasia, the current standard approach involves endoscopic mucosal resection and radiofrequency ablation. Highly select early esophageal cancers may in some cases also be mana作者: Conscientious 時(shí)間: 2025-3-23 14:20
Principles of Radiation Therapy,ion therapy (with 4-dimensional CT scans) and proton beam radiation are able to spare dose to critical structures such as heart and lung and limit overall treatment morbidity while delivering maximal cytotoxic doses to the primary tumor. The timing, sequence, and benefit of adding checkpoint inhibit作者: OATH 時(shí)間: 2025-3-23 19:41 作者: expound 時(shí)間: 2025-3-23 22:20
as chemoprevention.?Esophageal Cancer: Prevention, Diagnosis and Therapy?will assist specialists from various disciplines, including surgery,radiation therapy, gastroenterology, medical oncology and palliative medicine, in delivering optimal, up-to-date care to the benefit of patients..978-3-030-29834-0978-3-030-29832-6作者: 非實(shí)體 時(shí)間: 2025-3-24 05:57 作者: debble 時(shí)間: 2025-3-24 06:43 作者: Diastole 時(shí)間: 2025-3-24 14:44 作者: 珠寶 時(shí)間: 2025-3-24 18:01 作者: 簡(jiǎn)略 時(shí)間: 2025-3-24 22:02 作者: crutch 時(shí)間: 2025-3-25 02:46
Staging of Cancer of the Esophagus and Esophagogastric Junction,), and postneoadjuvant pathologic (ypTNM) stage groups, which are no longer shared among classifications. For pTNM, pT1 has been subcategorized as pT1a and pT1b for the subgrouping pStage I adenocarcinoma and squamous cell carcinoma. A new, simplified esophagus-specific regional lymph node map has b作者: 窒息 時(shí)間: 2025-3-25 07:14
Radiologic Assessment of Esophageal Cancer, different conventional anatomic modalities such as esophagograms, endoscopic ultrasound, CT, and MRI are explained. In addition, the role of PET/CT, a functional and anatomic modality, is illustrated. In this chapter, the specific role of each modality is explained for each of the pillars of stagin作者: ferment 時(shí)間: 2025-3-25 08:38 作者: 獨(dú)裁政府 時(shí)間: 2025-3-25 12:41 作者: capillaries 時(shí)間: 2025-3-25 19:44 作者: CESS 時(shí)間: 2025-3-25 21:34 作者: 微生物 時(shí)間: 2025-3-26 00:25 作者: 排出 時(shí)間: 2025-3-26 05:36 作者: negotiable 時(shí)間: 2025-3-26 11:36
Systemic Treatment for Metastatic or Recurrent Disease,ismal, where the malignancy is refractory to conventional cytotoxic chemotherapy and associated with poor prognosis. While therapeutic advances over the past several years have resulted in improved patient outcomes, the observed benefits have been modest, highlighting the need for the identification作者: 啞劇 時(shí)間: 2025-3-26 14:18
Immunotherapy in Esophageal Cancer,es has been shown to improve outcomes in a number of solid tumors, leading to their routine use in clinical practice. Early phase evaluation of immune checkpoint inhibitors demonstrated encouraging results in esophageal cancer, and studies in the chemorefractory setting have confirmed the activity o作者: appall 時(shí)間: 2025-3-26 20:32
Palliative Approaches in Esophageal Cancer,ophageal cancer remains a devastating disease in the world. Early diagnosis is difficult, since dysphagia, the common presentation symptom, occurs in late stage of the disease. When diagnosed, many patients miss the opportunity for surgical therapy. Also, patients with esophageal cancer are usually 作者: 飛鏢 時(shí)間: 2025-3-26 23:25 作者: SSRIS 時(shí)間: 2025-3-27 02:16
https://doi.org/10.1007/978-3-030-29832-6Staging of Esophageal Cancer; Surgery of Esophageal Cancer; Radiation Therapy in Esophageal Cancer; Sys作者: FAZE 時(shí)間: 2025-3-27 08:19
978-3-030-29834-0Springer Nature Switzerland AG 2020作者: 特征 時(shí)間: 2025-3-27 12:08
Introduction: Why We Wrote This Book,nciples of esophageal resection and reconstruction and details the techniques of the various approaches to esophagectomy including transhiatal esophagectomy, Ivor Lewis esophagectomy, Hole McKeown esophagectomy, and minimally invasive esophagectomy. This chapter also discusses common complications after esophagectomy and management strategies.作者: capsaicin 時(shí)間: 2025-3-27 15:30
Bioclimatology and Urban Bioclimatology,ent side effects, importance should be on providing increased calorie and protein needs to prevent loss of lean body mass. Evidence-based research will be provided on enteral nutrition perioperative and postoperative, in addition to advancing diet. Treatment toxicities and interventions are addressed as provided by a registered dietitian.作者: obligation 時(shí)間: 2025-3-27 18:22 作者: 移動(dòng) 時(shí)間: 2025-3-28 01:22
Nutritional Support in Esophageal Cancer,ent side effects, importance should be on providing increased calorie and protein needs to prevent loss of lean body mass. Evidence-based research will be provided on enteral nutrition perioperative and postoperative, in addition to advancing diet. Treatment toxicities and interventions are addressed as provided by a registered dietitian.作者: 可行 時(shí)間: 2025-3-28 05:28
Nabil F. Saba,Bassel F. El-RayesProvides a comprehensive overview of a multifaceted disease that is heterogeneous in terms of biology, anatomy and treatment approaches.Written by experts from very different disciplines, ranging from作者: endoscopy 時(shí)間: 2025-3-28 10:21
http://image.papertrans.cn/e/image/315213.jpg作者: amputation 時(shí)間: 2025-3-28 13:39 作者: LAY 時(shí)間: 2025-3-28 18:26 作者: expository 時(shí)間: 2025-3-28 19:16 作者: gain631 時(shí)間: 2025-3-29 00:45
https://doi.org/10.1007/978-3-319-77544-9ieved that virtually all EACs arise from BE. The incidence of BE appears to have increased over the last four decades for unclear reasons. Risk factors for BE include chronic gastroesophageal reflux, old age, male gender, obesity, and tobacco use; the majority of BE cases occur in males and approxim作者: 600 時(shí)間: 2025-3-29 03:13
https://doi.org/10.1007/978-981-16-9836-1being studied to try to prevent esophageal malignancy given its high burden of mortality and late stage at diagnosis..Proton pump inhibitors (PPIs), widely used in symptom management, have a role in controlling the progression of Barrett’s esophagus. Studies have moved towards defining optimum dosin作者: 細(xì)菌等 時(shí)間: 2025-3-29 07:33
Guriqbal Singh,Hari Ram,Navneet Aggarwal), and postneoadjuvant pathologic (ypTNM) stage groups, which are no longer shared among classifications. For pTNM, pT1 has been subcategorized as pT1a and pT1b for the subgrouping pStage I adenocarcinoma and squamous cell carcinoma. A new, simplified esophagus-specific regional lymph node map has b作者: encyclopedia 時(shí)間: 2025-3-29 12:31
Tri Wira Yuwati,Safinah Surya Hakim different conventional anatomic modalities such as esophagograms, endoscopic ultrasound, CT, and MRI are explained. In addition, the role of PET/CT, a functional and anatomic modality, is illustrated. In this chapter, the specific role of each modality is explained for each of the pillars of stagin作者: Dendritic-Cells 時(shí)間: 2025-3-29 18:31
https://doi.org/10.1007/978-3-319-41238-2acing the rate of growth of other major epithelial malignancies. Meanwhile, the incidence of esophageal squamous cell carcinoma (ESCC) has declined over several decades. While SCC is not felt to be preceded by a premalignant condition amenable to screening, EAC is preceded by Barrett’s esophagus (BE作者: 玉米 時(shí)間: 2025-3-29 21:08 作者: Ejaculate 時(shí)間: 2025-3-30 02:42
https://doi.org/10.1007/978-4-431-66899-2y with chemotherapy prior to surgery as a component of trimodality therapy. For patients who are unable to tolerate this aggressive approach, primary chemoradiation is utilized. Randomized data has established a benefit to concurrent chemoradiation over radiation alone whether administered in the ne作者: AMBI 時(shí)間: 2025-3-30 04:18 作者: 過(guò)份艷麗 時(shí)間: 2025-3-30 08:20
Climate Change and Renewable Energyproximately 95% of cases are due to squamous cell carcinoma (SCC) or adenocarcinoma (Torre et al., CA Cancer J Clin 65:87–108, 2012). In Western countries, there is an increasing incidence of adenocarcinoma with over 60% of cases attributed to adenocarcinomas, whereas worldwide the leading histology作者: DRAFT 時(shí)間: 2025-3-30 12:46 作者: 團(tuán)結(jié) 時(shí)間: 2025-3-30 16:39 作者: corn732 時(shí)間: 2025-3-31 00:23 作者: ellagic-acid 時(shí)間: 2025-3-31 04:27
https://doi.org/10.1057/9781137468796ophageal cancer remains a devastating disease in the world. Early diagnosis is difficult, since dysphagia, the common presentation symptom, occurs in late stage of the disease. When diagnosed, many patients miss the opportunity for surgical therapy. Also, patients with esophageal cancer are usually 作者: TEN 時(shí)間: 2025-3-31 05:49 作者: floaters 時(shí)間: 2025-3-31 13:00
C. Shaji,M. P. Sudev,M. V. Martininally, we touch upon theragnostic tests, including HER2, microsatellite instability, and PD-L1, that are performed in the pathology laboratory and provide information that identified patients who will benefit most from these targeted therapies.作者: prodrome 時(shí)間: 2025-3-31 15:13 作者: 極端的正確性 時(shí)間: 2025-3-31 17:38 作者: 無(wú)脊椎 時(shí)間: 2025-3-31 22:22
Pathology of Premalignant and Malignant Disease of the Esophagus,inally, we touch upon theragnostic tests, including HER2, microsatellite instability, and PD-L1, that are performed in the pathology laboratory and provide information that identified patients who will benefit most from these targeted therapies.作者: blister 時(shí)間: 2025-4-1 04:54 作者: Communal 時(shí)間: 2025-4-1 08:59
